Lamark Biotech
PrivateLast Round
Seed
Jul 1, 2025
Total Funding Raised
$804,300
Company Overview
Lamark Biotech operates in Healthcare & Life Sciences and is based in Ahmedabad. Its latest recorded funding round was a Seed round in July 2025.
Lamark Biotech is a biotechnology company that develops thermostable biologics using its proprietary ProteoStrong platform to reduce cold-chain dependency for life-saving therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Pharma Supply Chain
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lamark Biotech Comparables
Compare Lamark Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| EnsiliTech | 86% | |
| Jurata Thin Film | 84% | |
| Inaedis Inc. | 79% |
For institutional investors. Book with your work email.
Lamark Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jul 1, 2025 | ||||
| Seed | Mar 22, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Lamark Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| IAN Group | Seed |
| VIT-Technology Business Incubator | Seed |
| BioAngels | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
Monthly visitors increased 181% MoM, reaching 3K.
- Jan 20, 2026
Monthly visitors increased 1799% MoM, reaching 5.3K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingAug 18, 2026
Lamark Biotech Pvt. Ltd., a Venture Center-associated startup in Pune, is developing technology that reduces the dependence of essential medicines, including insulin and vaccines, on uninterrupted cold-chain storage as part of healthcare innovation in India on Aug 18th '26.
For institutional investors. Book with your work email.
Lamark Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Lamark Biotech's valuation, stock price, and market status.
Is Lamark Biotech a public or private company?
Lamark Biotech is a private company.
What is the current stock price of Lamark Biotech?
Lamark Biotech is a private company, so its shares have no public market price. Caplight tracks Lamark Biotech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Lamark Biotech worth (valuation)?
Valuation information for Lamark Biotech is not publicly available.
Can I buy Lamark Biotech stock?
Lamark Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Lamark Biotech's last funding round?
Lamark Biotech's most recent funding round was Seed on July 1, 2025.
Who are the main investors in Lamark Biotech?
Key investors in Lamark Biotech include VIT-Technology Business Incubator.
Will Lamark Biotech IPO soon?
No public IPO plans have been announced for Lamark Biotech.
How can I track Lamark Biotech secondary market activity?
Caplight tracks bids, offers, and trades in Lamark Biotech's shares on secondary markets.